Conveners
Session 13 - Applications of radioactive ion beams
- Magdalena Kowalska (CERN)
Electromagnetic isotope separation is an essential technology for the production of radionuclides with high radionuclidic purity, also those that are the “fuel” for nuclear medicine applications. Radionuclides for imaging and therapy are produced by charged particle induced reactions at accelerators or by neutron induced reactions in nuclear reactors. Yet, both methods require as prior step...
β-NMR is a powerful tool which takes advantage of the anisotropic nature of β decay, to obtain information about the environment in which the radioisotope is implanted or to study the properties of the radioisotope itself. Nuclei are first polarized, then implanted into a crystal or sample of interest from which β-decay intensities are measured in opposing directions. The relevant information...
We will present a novel production system based on the ISOL method (Isotope Separation On-Line) for intense mass separated $^{11}$C beams for PET-aided hadron therapy. Hadron therapy, and particularly carbon therapy, is a very precise treatment for localized tumors where the tumor is irradiated with a pure, monoenergetic and high intensity particle beam. Carbon therapy significantly reduces...
The new facility CERN-MEDICIS produces isotopes using the CERN proton beam at 1.4 GeV coming from the CERN Proton Booster. The produced radioisotopes are dedicated for medical applications. A wide range of innovative radionuclides can be produced through its off-line mass separator. Indeed the mass separation allows the production of radionuclides which are not available at sufficient specific...